BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 34577614)

  • 1. Antimicrobial Properties of Antidepressants and Antipsychotics-Possibilities and Implications.
    Caldara M; Marmiroli N
    Pharmaceuticals (Basel); 2021 Sep; 14(9):. PubMed ID: 34577614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-Antibiotic Drug Repositioning as an Alternative Antimicrobial Approach.
    Barbarossa A; Rosato A; Corbo F; Clodoveo ML; Fracchiolla G; Carrieri A; Carocci A
    Antibiotics (Basel); 2022 Jun; 11(6):. PubMed ID: 35740222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antidepressants, antimicrobials or both? Gut microbiota dysbiosis in depression and possible implications of the antimicrobial effects of antidepressant drugs for antidepressant effectiveness.
    Macedo D; Filho AJMC; Soares de Sousa CN; Quevedo J; Barichello T; Júnior HVN; Freitas de Lucena D
    J Affect Disord; 2017 Jan; 208():22-32. PubMed ID: 27744123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repurposed Drugs as Potential Therapeutic Candidates for the Management of Alzheimer's Disease.
    Shoaib M; Kamal MA; Rizvi SMD
    Curr Drug Metab; 2017; 18(9):842-852. PubMed ID: 28595531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination therapy: the propitious rationale for drug development.
    Phougat N; Khatri S; Singh A; Dangi M; Kumar M; Dabur R; Chhillar AK
    Comb Chem High Throughput Screen; 2014 Jan; 17(1):53-67. PubMed ID: 24138510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The FICI paradigm: Correcting flaws in antimicrobial in vitro synergy screens at their inception.
    Gómara M; Ramón-García S
    Biochem Pharmacol; 2019 May; 163():299-307. PubMed ID: 30836058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug Repurposing for the Management of Depression: Where Do We Stand Currently?
    Mohammad Sadeghi H; Adeli I; Mousavi T; Daniali M; Nikfar S; Abdollahi M
    Life (Basel); 2021 Jul; 11(8):. PubMed ID: 34440518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacogenomics: A focus on antidepressants and atypical antipsychotics.
    Lister JF
    Ment Health Clin; 2016 Jan; 6(1):48-53. PubMed ID: 29955447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective Estrogen Receptor Modulators (SERMs): Mechanistic Insights Against Microbial Infections.
    Garg A; Singh B; Sharma R; Singh A; Kumar A
    Curr Mol Med; 2020; 20(2):102-115. PubMed ID: 31622201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A High-Throughput Screening Approach To Repurpose FDA-Approved Drugs for Bactericidal Applications against Staphylococcus aureus Small-Colony Variants.
    Trombetta RP; Dunman PM; Schwarz EM; Kates SL; Awad HA
    mSphere; 2018 Oct; 3(5):. PubMed ID: 30381352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends in Psychotropic Dispensing Among Older Adults with Dementia Living in Long-Term Care Facilities: 2004-2013.
    Vasudev A; Shariff SZ; Liu K; Burhan AM; Herrmann N; Leonard S; Mamdani M
    Am J Geriatr Psychiatry; 2015 Dec; 23(12):1259-1269. PubMed ID: 26525997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tricyclic antidepressants inhibit Candida albicans growth and biofilm formation.
    Caldara M; Marmiroli N
    Int J Antimicrob Agents; 2018 Oct; 52(4):500-505. PubMed ID: 29990546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repurposing of Antimicrobial Agents for Cancer Therapy: What Do We Know?
    Pfab C; Schnobrich L; Eldnasoury S; Gessner A; El-Najjar N
    Cancers (Basel); 2021 Jun; 13(13):. PubMed ID: 34206772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanomedicines for the Delivery of Antimicrobial Peptides (AMPs).
    Teixeira MC; Carbone C; Sousa MC; Espina M; Garcia ML; Sanchez-Lopez E; Souto EB
    Nanomaterials (Basel); 2020 Mar; 10(3):. PubMed ID: 32244858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined treatment with atypical antipsychotics and antidepressants in treatment-resistant depression: preclinical and clinical efficacy.
    Rogóż Z
    Pharmacol Rep; 2013; 65(6):1535-44. PubMed ID: 24553002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carcinogenicity of psychotropic drugs: A systematic review of US Food and Drug Administration-required preclinical in vivo studies.
    Amerio A; Gálvez JF; Odone A; Dalley SA; Ghaemi SN
    Aust N Z J Psychiatry; 2015 Aug; 49(8):686-96. PubMed ID: 25916799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repurposing Antipsychotics for Cancer Treatment.
    Vlachos N; Lampros M; Voulgaris S; Alexiou GA
    Biomedicines; 2021 Nov; 9(12):. PubMed ID: 34944601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinically relevant drug interactions with new generation antidepressants and antipsychotics].
    Eckert A
    Ther Umsch; 2009 Jun; 66(6):485-92. PubMed ID: 19496045
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.